相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Abietic acid attenuates RANKL induced osteoclastogenesis and inflammation associated osteolysis by inhibiting the NF-KB and MAPK signaling
Dinesh Thummuri et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Recent advances in osteoclast biology
Takehito Ono et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2018)
Tatarinan N inhibits osteoclast differentiation through attenuating NF-κB, MAPKs and Ca2+-dependent signaling
Yuxin Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Platycodin D Inhibits Osteoclastogenesis by Repressing the NFATc1 and MAPK Signaling Pathway
Jae Ho Choi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Anemonin attenuates osteoarthritis progression through inhibiting the activation of IL-1β/NF-κB pathway
Zuqiang Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Tatarinan O, a lignin-like compound from the roots of Acorus tatarinowii Schott inhibits osteoclast differentiation through suppressing the expression of c-Fos and NFATc1
Xiaohan Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
DC-STAMP: A Key Regulator in Osteoclast Differentiation
Ya-Hui Chiu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
IL-33 inhibits RANKL-induced osteoclast formation through the regulation of Blimp-1 and IRF-8 expression
Hiroyasu Kiyomiya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Negative regulation of RelA phosphorylation: Emerging players and their roles in cancer
Xinyuan Lu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
9-Hydroxy-6,7-dimethoxydalbergiquinol inhibits osteoclast differentiation through down-regulation of Akt, c-Fos and NFATc1
Ju-Young Kim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Secretion of a Truncated Osteopetrosis-associated Transmembrane Protein 1 (OSTM1) Mutant Inhibits Osteoclastogenesis through Down-regulation of the B Lymphocyte-induced Maturation Protein 1 (BLIMP1)-Nuclear Factor of Activated T Cells c1 (NFATc1) Axis
Bongjin Shin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts
Janja Zupan et al.
BIOCHEMIA MEDICA (2013)
Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70
Annette I. Garbe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
New insights into osteoclastogenic signaling mechanisms
Tomoki Nakashima et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
New regulation mechanisms of osteoclast differentiation
Tomoki Nakashima et al.
SKELETAL BIOLOGY AND MEDICINE II: BONE AND CARTILAGE HOMEOSTASIS AND BONE DISEASE (2011)
Inactivation of Glycogen Synthase Kinase-3β Is Required for Osteoclast Differentiation
Hyun Duk Jang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors
Baohong Zhao et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Blimp1-mediated repression of negative regulators is required for osteoclast differentiation
Keizo Nishikaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway
Myeung Su Lee et al.
JOURNAL OF IMMUNOLOGY (2009)
Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes
Yen-Hua Huang et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2008)
NFATc1 induces osteoclast fusion via up-regulation of atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP)
Kabsun Kim et al.
MOLECULAR ENDOCRINOLOGY (2008)
The osteoclast: A multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell
Zvi Bar-Shavit
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
MafB negatively regulates RANKL-mediated osteoclast differentiation
Kabsun Kim et al.
BLOOD (2007)
The molecular understanding of osteoclast differentiation
Masataka Asagiri et al.
BONE (2007)
v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation
Seoung-Hoon Lee et al.
NATURE MEDICINE (2006)
ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-κB transactivation during oxidative stress in skeletal myoblasts
Eirini Kefaloyianni et al.
CELLULAR SIGNALLING (2006)
NFATc1 regulation of the human β3 integrin promoter in osteoclast differentiation
Tania N. Crotti et al.
GENE (2006)
Effect of anemonin on NO, ET-1 and ICAM-1 production in rat intestinal microvascular endothelial cells
HQ Duan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2006)
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
M Asagiri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Phosphorylation of RelA/p65 on serine 536 defines an IκBα-independent NF-κB pathway
CY Sasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1
J Bohuslav et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Overview of osteoporosis: pathophysiology and determinants of bone strength
CM Bono et al.
EUROPEAN SPINE JOURNAL (2003)
Role of osteoclast extracellular signal-regulated kinase (ERK) in cell survival and maintenance of cell polarity
H Nakamura et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)
L Vermeulen et al.
EMBO JOURNAL (2003)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
IκB independent control of NF-κB activity by modulatory phosphorylations
ML Schmitz et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts
T Miyazaki et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
